apl. Prof. Dr. Jürgen Rech

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still’s disease in Germany () Friedrich R, Kernder A, Blank N, Ernst D, Henes J, Keyßer G, Klemm P, et al. Journal article Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease (2025) Topping J, Chang L, Nadat F, Poulter JA, Ibbotson A, Lara-Reyna S, Watson CM, et al. Journal article Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry (2025) Oommen PT, Kallinich T, Rech J, Blank N, Weber-Arden J, Kuemmerle-Deschner JB Journal article, Original article First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study (2025) Kernder A, Filla T, Friedrich R, Blank N, Ernst D, Henes J, Keyßer G, et al. Journal article Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndrome (2024) Reuner M, Krehbiel J, Rech J, Greiner B, Schäfer I, Herold R, Morawa E, Erim Y Journal article Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey (2024) Rech J, Schett G, Tufan A, Kuemmerle-Deschner JB, Özen S, Tascilar K, Geck L, et al. Journal article Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry (2024) Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Götze B, Oommen PT, Rech J, Krickau T, et al. Journal article, Original article 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice (2024) Mandl P, D'Agostino MA, Navarro-Compán V, Geßl I, Sakellariou G, Abhishek A, Becce F, et al. Journal article Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial (2024) Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schönau V, Hueber A, et al. Journal article Reversing the Inflammatory Process—25 Years of Tumor Necrosis Factor-α Inhibitors (2023) Muth KN, Rech J, Losch FO, Hörning A Journal article, Review article